ProMIS Neurosciences is trading at $3.71, up 5.26% in live trading, with no clear company-specific catalyst confirmed.

  • On November 5, ProMIS Neurosciences announced November conference appearances, including presentations and fireside chats by its CEO.
  • Major indexes and biotech were lower, so broader weakness does not explain the gain.
  • No trading-volume detail was confirmed.